- Open Access
Comparative neonatal outcomes in singleton births from blastocyst transfers or cleavage-stage embryo transfers: a systematic review and meta-analysis
Reproductive Biology and Endocrinologyvolume 15, Article number: 36 (2017)
Comparative neonatal outcomes with respect to singleton births from blastocyst transfers or cleavage-state embryo transfers are controversial with respect to which method is superior. Many studies have yielded contradictory results. We performed a systematic review and meta-analysis for the purpose of comparing neonatal outcomes in single births following IVF/ICSI.
We searched the Medline, Embase and Cochrane Central Register of Clinical Trials (CCTR) databases until October 2016. Studies and trials that contained neonatal outcomes for singleton births were included. Data were extracted in 2 × 2 tables. The analysis was performed using Rev Man 5.1 software. Risk ratios (RRs) and risk differences, with 95% confidence intervals, were calculated to assess the results of each outcome. Subgroups were applied in all outcomes. Newcastle-Ottawa scale (NOS) checklists were used to assess the quality of the referenced studies.
Twelve studies met the criteria in this meta-analysis. There was a high risk of preterm birth after blastocyst embryo transfer versus the risk after cleavage-stage transfer (RR: 1.11, 95% CI: 1.01–1.22). For the “only fresh” subgroup, the outcome was coincident (RR: 1.16, 95% CI: 1.06–1.27). For the “fresh and frozen” and “only frozen” subgroups, there were no differences. Patients who received fresh blastocyst embryo transfers had a high risk of very preterm births (RR: 1.16, 95% CI: 1.02–1.31). Finally, cleavage-stage embryo transfers were associated with a high risk of infants who were small for gestational age (0.83, 95% CI: 0.76–0.92) and a low risk of those who were large for gestation age (1.14, 95% CI: 1.04–1.25).
The risks of preterm and very preterm births increased after fresh blastocyst transfers versus the risks after fresh cleavage-stage embryo transfers. However, in frozen embryo transfers, there were no differences. Blastocyst embryo transfers resulted in high risks of infants who were large for gestational age, and cleavage-stage embryo transfers resulted in high risks of infants who were small for gestational age.
Assisted reproduction technology (ART) is frequently employed in modern obstetrics. According to a report by the International Committee for Monitoring Assisted Reproductive Technologies World, the percentage of babies born as a result of ART increased by an estimated average of 9.1% per year from 2008 to 2010. In addition, the global rate of single embryo transfers (SETs) increased from 25.7% in 2008 to 30.0% in 2010 .
With the increasing proportion of SETs, neonatal outcomes following SETs are receiving increasing attention, especially with respect to blastocyst transfers versus cleavage-stage embryo transfers. A recent meta-analysis found that cleavage-stage embryo transfers were associated with lower relative risks of preterm births and very preterm deliveries versus risks after blastocyst transfers. Another meta-analysis showed that increased risks of preterm births and congenital anomalies were associated with blastocyst transfers . The most recent meta-analysis indicated that blastocyst transfers were associated with high risks of preterm births, very preterm births and infants who are large for gestational age . However, the reported outcomes of blastocyst transfers are not always consistent. In a study by the reproductive unit of McGill University Health Center, no significant differences in the risks associated with obstetric and perinatal outcomes were found . Another report showed that there was no significant difference in preterm births . Due to these conflicting data, there is an urgent need to provide an update on the available evidence for neonatal outcomes in singleton births after blastocyst transfers versus outcomes after cleavage-stage embryo transfers.
In a recent meta-analysis, fresh embryo transfers were associated with a high risk of preterm births and low birth weights versus risks after frozen embryo transfers . Another meta-analysis also showed that preterm births, low birth weights and rates of infants who were small for gestational age and perinatal mortality were lower in women who received frozen embryos compared to outcomes in those who received fresh embryos . In some studies, however, the blastocyst and cleavage-stage transfer groups combined women who received fresh and frozen embryo transfers, which likely confounded the results. To eliminate this confounding effect, we separated these subgroups.
The objective of this systematic review and meta-analysis was to compare neonatal outcomes in singleton births after blastocyst transfers versus outcomes after cleavage-stage embryo transfer.
Data sources and searches
A systematic literature search was performed on Medline, Embase and Cochrane Central Register of Clinical Trials (CCTR) through October 2016. We searched the literature using the following key words: blastocyst, cleavage, embryo transfer, outcomes, very preterm birth, preterm birth, small for gestational age, large for gestational age, low birth weight and very low birth weight. Two authors (WXL and DMZ) independently conducted the searches and selected the studies to be included. Differences of opinion were resolved after team discussions. Duplicate studies were carefully considered to include comprehensive and high quality studies. Study authors were contacted when more information was needed. Data were extracted using pre-design forms.
Original studies reporting neonatal outcomes following IVF/ICSI for singleton embryo transfers were included. Studies were sorted by the stage of the embryo at transfer. Cleavage-stage embryos were defined as those at day 2/3/4, and blastocyst embryos were defined as those at day 5/6.
Studies were excluded if there was no control group, if the neonatal outcomes we needed were not measured, or if there was no independent data from singleton births. Additionally, data gathered after gamete intra-fallopian transfer (GIFT) and preimplantation genetic diagnosis (PGD) were excluded.
The included outcomes were infants who were small for gestational age or large for gestational age, preterm births (delivery < 37 weeks), very preterm births (delivery < 32 weeks), low birth weights (birth weight < 2500 g), and very low birth weights (birth weight < 1500 g).
For each outcome, data was extracted in 2 × 2 tables. A meta-analysis was attempted where appropriate. Analyses was performed using the Rev Man 5.1 software (The Nordic Cochrane Center). For binary (or dichotomous) studies, risk ratios (RRs) and 95% confidence intervals were calculated to assess the results of each outcome. A quality assessment of each included study was performed independently by two authors (WXL and DMZ). Any disagreements regarding the type and quality of the studies were resolved via team discussions. The checklists from the Newcastle-Ottawa scale (NOS) were used to assess the quality of studies. If the study had an NOS score ≥ 6, it was regarded as a high-quality study.
Assessment of heterogeneity
Meta-analyses were performed using random effect models, and we assessed the studies with χ2 tests. If an outcome had a low P value (or a large χ2 statistic relative to its degree of freedom), this suggested that the evidence had heterogeneity . Additionally, heterogeneity was assessed based on the I2 statistic . If the I2 value was > 50%, the evidence was deemed as having moderate heterogeneity. A sensitivity analysis was performed by excluding low quality studies (NOS score < 6).
Assessment of reporting biases
Funnel plots were constructed when an outcome was reported in more than eight studies to test for reporting bias.
Results of the searches
After searching on Medline, Embase and Cochrane Central Register of Clinical Trials (CCTR) through October 2016, 1178 studies were found (Fig. 1). After reading the titles and abstracts, 37 studies were included. After reading the full text, 12 studies were included in the final analysis. Seventeen studies were excluded because they did not report on the parameters in which we were interested. Three studies [10,11,12] overlapped with a study from Sweden . In addition, one study  and its matched cohort  had some duplicate data . One study  partially overlapped with another . One study was excluded because it defined day 2/3 as the cleavage stage and day 4/5 as the blastocyst stage , which was not consistent with the stage definitions in the other studies. Lastly, one study did not separate the blastocyst and cleavage stages in some aspects , and the data were not in the format we needed.
Twelve studies were included in this analysis. They compared neonatal outcomes in singleton births after blastocyst transfers (day 5/6) versus outcomes after cleavage-stage embryo transfers (day 2/3/4) after IVF/ICSI.
Methodology of the included studies
Twelve retrospective unmatched cohort studies were included. All studies scored high (≥6) on NOS checklists. Data were pooled from databases except in one study .
Populations in the included studies
Despite strict inclusion criteria, there was still variation in the populations of the 12 studies. Most of the studies included patients undergoing IVF/ICSI, but two studies included couples only undergoing IVF [20, 21]. Four studies [6, 13, 22, 23] confounded fresh and frozen embryo transfers, while two clearly separated those variables [13, 23]. Others included only fresh embryo transfers.
Exposure in the included studies
In the 12 studies, cleavage-stage transfer was defined as transferring the embryo on day 2/3/4, and blastocyst transfer was defined as transfers on day 5/6. These details are included in Table 1.
Results of the outcome measures
Preterm birth (delivery at < 37 weeks)
Ten studies covered preterm births (delivery at < 37 weeks). The RR of delivery at < 37 weeks was 1.11 (1.01–1.22) in singleton births after blastocyst transfers compared with the risks after cleavage-stage transfers (Fig. 2). The Q statistic P-value was < 0.00001, and the I2 statistic = 85%, indicating high heterogeneity. For all of the studies with a high NOS score, a sensitivity analysis did not improve the outcomes.
As mentioned in the introduction, fresh embryo transfer is associated with a high risk of preterm birth. We attempted to parse out the confounding factors to further explore this assessment, but unfortunately, two studies mixed fresh and frozen embryos in their analyses. Therefore, we do not know the exact proportions of fresh/frozen embryos in the blastocyst/cleavage-stage groups for these studies; hence, we set up three subgroups for our analysis: “fresh and frozen”, “only fresh” and “only frozen”. In the “only fresh” subgroup, the RR of delivery at < 37 weeks was 1.16 (1.06–1.27). In the “fresh and frozen” subgroup, the RR of delivery at < 37 weeks was 0.98 (0.92–1.04). Finally, in the “only frozen” subgroup, the RR of delivery at < 37 weeks was 1.11 (0.99–1.25). Based on these data, we concluded that there was no significant difference between the “only frozen” and “fresh and frozen” subgroups. However, in the “only fresh” subgroup, a high risk of preterm birth after blastocyst embryo transfer versus the risk after cleavage-stage embryo transfer was observed.
Lastly, no publication bias was found in the funnel plot (Fig. 3).
Very preterm birth (delivery at < 32 weeks)
Eight studies covered very preterm births (delivery at < 32 weeks). The RR of delivery at < 32 weeks was 1.03 (0.88–1.20). The results of the outcome analysis indicate that the risk of delivery at < 32 weeks was similar in singleton births after blastocyst transfers and cleavage-stage transfers. However, we found that the risk of a very preterm birth became higher after a fresh blastocyst transfer versus after a fresh cleavage-stage transfer (RR: 1.16, 95% CI: 1.02–1.31), but no differences were found between the “fresh and frozen” and “only frozen” subgroups (Fig. 4).
The funnel plot did not demonstrate any publication bias (Fig. 5).
Low birth weight (birthweight < 2500 g)
Eight studies covered low birth weights, defined as < 2500 g. The RR of a birthweight < 2500 g was 0.97 (0.90, 1.04) in singleton births after blastocyst transfers compared with the risk after cleavage-stage transfers (Fig. 6). The Q statistic P-value = 0.0007, and the I2 statistic = 69%, indicating high heterogeneity. For all of studies with a high NOS score, a sensitivity analysis did not improve the outcomes.
As mentioned in the introduction, fresh embryo transfer was associated with a high risk of a low birth weight. Therefore, we used the same method as in analyzing preterm births. In the “only fresh” subgroup, we found that the RR of a low birth weight was 1.01 (0.92–1.10). In the “only frozen” subgroup, the RR of a low birth weight was 0.81 (0.58–1.14). In addition, the RR of the “fresh and frozen” subgroup was 0.95 (0.89–1.02).
The funnel plot did not show any publication bias (Fig. 7).
Very low birth weight (birthweight < 1500 g)
In our meta-analysis, six studies covered very low birth weights. The RR of a very low birth weight was 0.99 (0.86–1.14) in singleton births after a blastocyst transfer compared with the risks after a cleavage-stage transfer. In addition, the Q statistic P-value = 0.45, and the I2 statistic = 0%. The results indicate that there was no increased risk of a very low birth weight after blastocyst transfer versus the risk after a cleavage-stage transfer (Fig. 8).
Small for gestational age (< 10th percentile or < -2 SD)
In this meta-analysis, eight studies covered small for gestational age outcomes. However, the definition of this outcome was different across studies. Most studies defined it as < 10th percentile on the intrauterine growth chart. However, small for gestational age was defined as < -2SD in this study. The RR of infants being small for gestational age was 0.83 (0.76–0.92) in singleton births after a blastocyst transfer when compared with the risk after a cleavage-stage transfer (Fig. 9). The Q statistic P-value = 0.04, and the I2 statistic = 63%, which indicates high heterogeneity. For all studies with a high NOS score, a sensitivity analysis did not improve the results.
As discussed previously, fresh embryo transfers are associated with a high risk of infants being small for gestational age; so, we employed the same analytical methods as for preterm births. In the “only fresh” subgroup, we found that the RR of infants being small for gestational age was 0.83 (0.74–0.94), and there was low heterogeneity. In the “only frozen” subgroup, the RR of infants being small for gestational age was 0.59 (0.32–1.06). The RR for the “fresh and frozen” subgroup was 0.92 (0.86–0.97).
The funnel plot did not reveal any publication bias (Fig. 10).
Large for gestational age (> 10th percentile or > -2 SD)
In this meta-analysis, six studies covered large for gestational age outcomes. The RR of infants being large for gestational age was 1.14 (1.04–1.25) in singleton births after a blastocyst transfer compared with the risk after a cleavage-stage transfer (Fig. 11), and the Q statistic P-value = 0.05, with a corresponding I2 statistic = 50%. These results indicate that there was no increased risk of a large for gestational age outcome after a blastocyst transfer compared with the risk after a cleavage-stage transfer.
In our meta-analysis, we observed a higher risk for both preterm births and very preterm births after blastocyst embryo transfers versus the risks after cleavage-stage embryo transfers. We did not find obvious differences in frozen embryo transfer outcomes. In addition, we found a decreased risk of infants being small for gestational age associated with blastocyst embryo transfers and an increased risk of infants being large for gestation age associated with cleavage-stage embryo transfers. Finally, we did not find an association between blastocyst embryo transfers and cleavage-stage embryo transfers in relation to the other aspects of our study.
Up to now, two systematic meta-analyses have analyzed the outcomes of blastocyst and cleavage-stage embryo transfers. One compared obstetric and perinatal outcomes between the two groups, and the other compared only neonatal outcomes. We included twelve studies in our systematic meta-analysis, creating a larger data set than either of the two previous studies performed.
In addition, we analyzed whether embryos used either frozen or fresh affects these outcomes. Aside from the two meta-analyses we mentioned previously, we also found a recent study concluding that birth weight (frozen versus fresh: 3310.6 ± 579.5 versus 3243.7 ± 558.6, P = 0.008) and the frequency of infant being small for gestational age (frozen versus fresh: 6.6% versus 10.2%, P = 0.005) had different outcomes in singleton births . In summary, we concluded that mixing fresh and frozen embryos into the same comparison group is a confounding factor.
Although our study inclusion criteria were strict, there was still variability between the studies we used, indicating that our meta-analysis possesses some limitations.
In several studies, the days compared for embryo transfer were different. For example, in one study, days 2–4 was compared with days 5–6 . Two studies compared day 3 with days 5–6 [20, 21, 24, 25]. Additional studies compared days 2–3 with days 5–6 [6, 13, 26], and one study failed to mention the exact days that were compared altogether . The last three studies compared day 2 with days 5–6 , days 2–3 with day 5 , and day 3 with day 5 . An additional confounder in some studies arose as a result of including frozen embryo transfers and fresh embryo transfers in the same comparison group [6, 13, 22, 23]. It is also difficult to know the quality of the embryos and the method that was employed for freezing embryos in each study. The outcomes of vitrified embryo transfer and slow-freezing embryo transfer are different. One study showed that the median birth weight of babies born from slow-freezing embryos is lower than that of those born from vitrified embryos . In a previous study, they included patients in their center from January 2006 to May 2011. For the singleton birth group, birth weight (3455.3 ± 482.0) after vitrified embryo transfer was higher than after slow-freezing embryo transfer (3352.3 ± 500.7) (P = 0.0001), and the media for extending embryo cultures was also different.
In addition, the patients in these studies had variant characteristics, such as maternal age, parity, smoking, body mass index, years of involuntary childlessness, and history of preterm birth. For example, the mean age of patients at the time of blastocyst transfer was younger than for those undergoing cleavage-stage transfer in some studies [6, 15, 20, 22, 24]. In one study, however, there was no difference in the mean age between these groups . Without individual data, we cannot eliminate these potentially confounding variables. Definitions for outcomes also differed in some instances between different studies, and some studies may have used donor oocytes. For some subgroups, the number of included studies was small. We need more data to eliminate the risk of bias.
Finally, we used retrospective cohort studies. Data from randomized, controlled trials would be more reliable in assessing these outcomes.
Clinical implications of the study
In our meta-analysis, we found a high risk of preterm birth after blastocyst embryo transfer versus the risk after cleavage-stage embryo transfer, especially in the “only fresh” subgroup. In the other subgroups, however, there were no differences. We also observed that fresh blastocyst embryo transfer had a high risk of very preterm birth. In addition, people who underwent blastocyst embryo transfers were at a low risk of having infants who were small for gestational age and a high risk of having infants who were large for gestation age versus the risks following cleavage-stage embryo transfers. We do not have an absolute conclusion as to which method of embryo transfer is superior for patients; so, we decided to expand our study to also include pregnancy outcomes. A recent study found that live birth rates per started cycle (31.3% versus 37.8%, P = 0.041) were significantly lower after transferring fresh single cleavage-stage embryos compared to rates after transferring blastocysts.
However, the cumulative live birth rates (52.6% versus 52.5%, P = 0.989) were not significantly different between cleavage-stage and blastocyst embryo transfers . Additional studies have reached the same conclusion as professor De Vos. In a recent meta-analysis that included five randomized control trials, it was found that there was no difference in cumulative pregnancy rates (0.82, 0.60–1.12) between cleavage-stage and blastocyst embryo transfers .
In most cases, cleavage-stage transfers result in more available embryos, and blastocyst transfers may confer a lesser chance of a successful transfer. Whether either method is better than the other remains to be determined.
For many of the aspects we investigated, randomized, controlled trials are needed to more accurately assess the outcomes. In addition, studies where embryos are of an unknown status in terms of whether they are frozen or fresh present the potential for confounding effects. Of course, the reasons for differential outcomes could also improve the efficacy of ART. In addition, follow-up investigations need to be updated to include babies’ growth and developmental progress.
Assisted reproduction technology
Assisted reproductive technology
Intracytoplasmic sperm injection
In vitro fertilization
Low birth weight
Preterm birth weight
Single embryo transfer.
Small for gestational age
Very preterm birth weight
Dyer S, Chambers GM, de Mouzon J, Nygren KG, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Adamson GD. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010. Hum Reprod. 2016;31:1588–609.
Maheshwari A, Kalampokas T, Davidson J, Bhattacharya S. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of blastocyst-stage versus cleavage-stage embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril. 2013;100:1615-1621.e1611-1610.
Dar S, Lazer T, Shah PS, Librach CL. Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:439–48.
Martins WP, Nastri CO, Rienzi L, van der Poel SZ, Gracia CR, Racowsky C. Obstetrical and perinatal outcomes following blastocyst transfer compared to cleavage transfer: a systematic review and meta-analysis. Hum Reprod. 2016;31:2561–9.
Oron G, Nayot D, Son WY, Holzer H, Buckett W, Tulandi T. Obstetric and perinatal outcome from single cleavage transfer and single blastocyst transfer: a matched case-control study. Gynecol Endocrinol. 2015;31:469–72.
Chambers GM, Chughtai AA, Farquhar CM, Wang YA. Risk of preterm birth after blastocyst embryo transfer: a large population study using contemporary registry data from Australia and New Zealand. Fertil Steril. 2015;104:997–1003.
Zhao J, Xu B, Zhang Q, Li YP. Which one has a better obstetric and perinatal outcome in singleton pregnancy, IVF/ICSI or FET?: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2016;14:51.
Higgins J: Green S. Cochrane Handbook for Systematic Reviews of Interventions. 5th ed. Chichester: John Wiley and Sons Ltd; 2011.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C. Factors affecting obstetric outcome of singletons born after IVF. Hum Reprod. 2011;26:2878–86.
Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Blastocyst versus cleavage stage transfer in in vitro fertilization: differences in neonatal outcome? Fertil Steril. 2010;94:1680–3.
Wikland M, Hardarson T, Hillensjo T, Westin C, Westlander G, Wood M, Wennerholm UB. Obstetric outcomes after transfer of vitrified blastocysts. Hum Reprod. 2010;25:1699–707.
Ginstrom Ernstad E, Bergh C, Khatibi A, Kallen KB, Westlander G, Nilsson S, Wennerholm UB. Neonatal and maternal outcome after blastocyst transfer: a population-based registry study. Am J Obstet Gynecol. 2016;214:378.e371–10.
Oron G, Son WY, Buckett W, Tulandi T, Holzer H. The association between embryo quality and perinatal outcome of singletons born after single embryo transfers: a pilot study. Hum Reprod. 2014;29:1444–51.
Oron G, Sokal-Arnon T, Son WY, Demirtas E, Buckett W, Zeadna A, Holzer H, Tulandi T. Extended embryo culture is not associated with increased adverse obstetric or perinatal outcome. Am J Obstet Gynecol. 2014;211:165.e161-167.
Li Z, Wang YA, Ledger W, Edgar DH, Sullivan EA. Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study. Hum Reprod. 2014;29:2794–801.
Schwarzler P, Zech H, Auer M, Pfau K, Gobel G, Vanderzwalmen P, Zech N. Pregnancy outcome after blastocyst transfer as compared to early cleavage stage embryo transfer. Hum Reprod. 2004;19:2097–102.
Belva F, Bonduelle M, Roelants M, Verheyen G, Van Landuyt L. Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer. Hum Reprod. 2016;31:1610–20.
Martin L, Frapsauce C, Royere D, Guerif F. Single pregnancy outcome after blastocyst transfer: comparison with cleavage stage embryo transfers. Gynecol Obstet Fertil. 2012;40:291–5.
Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Extended embryo culture and an increased risk of preterm delivery. Obstet Gynecol. 2012;120:69–75.
Zhu J, Lin S, Li M, Chen L, Lian Y, Liu P, Qiao J. Effect of in vitro culture period on birthweight of singleton newborns. Hum Reprod. 2014;29:448–54.
Fernando D, Halliday JL, Breheny S, Healy DL. Outcomes of singleton births after blastocyst versus nonblastocyst transfer in assisted reproductive technology. Fertil Steril. 2012;97:579–84.
Ishihara O, Araki R, Kuwahara A, Itakura A, Saito H, Adamson GD. Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril. 2014;101:128–33.
Dar S, Librach CL, Gunby J, Bissonnette F, Cowan L. Increased risk of preterm birth in singleton pregnancies after blastocyst versus Day 3 embryo transfer: Canadian ART Register (CARTR) analysis. Hum Reprod. 2013;28:924–8.
Maxwell SM, Melzer-Ross K, McCulloh DH, Grifo JA. A comparison of pregnancy outcomes between day 3 and day 5/6 embryo transfers: does day of embryo transfer really make a difference? J Assist Reprod Genet. 2015;32:249–54.
Mäkinen S, Söderström-Anttila V, Vainio J, Suikkari AM, Tuuri T. Does long in vitro culture promote large for gestational age babies? Hum Reprod. 2013 Mar;28(3):828-34. doi:10.1093/humrep/des410. Epub 2012 Dec 11. PubMed PMID:23232355.
De Vos A, Janssens R, Van de Velde H, Haentjens P, Bonduelle M, Tournaye H, Verheyen G. The type of culture medium and the duration of in vitro culture do not influence birthweight of ART singletons. Hum Reprod. 2015;30:20–7.
Liu SY, Teng B, Fu J, Li X, Zheng Y, Sun XX. Obstetric and neonatal outcomes after transfer of vitrified early cleavage embryos. Hum Reprod. 2013;28:2093–100.
De Vos A, Van Landuyt L, Santos-Ribeiro S, Camus M, Van de Velde H, Tournaye H, Verheyen G. Cumulative live birth rates after fresh and vitrified cleavage-stage versus blastocyst-stage embryo transfer in the first treatment cycle. Hum Reprod. 2016;31(11):2442–9. Epub 2016 Sep 12. PubMed PMID:27619768.
Glujovsky D, Farquhar C. Cleavage-stage or blastocyst transfer: what are the benefits and harms? Fertil Steril. 2016;106:244–50.
We acknowledge the professional manuscript editing services of American Journal Experts.
We did not receive any funding for this study.
Availability of data and material
All data are included in this article and its additional files.
WXL and DMZ conducted the literature searches, selected the studies to be included and extracted the data. ZJW, LZH, GYC and WBJ examined the data, made forms and performed analyses. DMZ was involved in drafting this article. All authors approved the final version of the manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.